O6-Methylguanine-DNA Methytransferase (MGMT) Immunohistochemistry as a Predictor of Resistance to Temozolomide in Primary CNS Lymphoma

被引：0
|
作者：
Jiang, X.
Reardon, D. A.
Desjardins, A.
Vredenburgh, J. J.
Quinn, J. A.
Austin, A. D.
Herndon, J. E.
McLendon, R. E.
Friedman, H. S.
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Univ N Carolina, Chapel Hill, NC USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1620
引用
收藏
页码：382A / 382A
页数：1
相关论文
共 50 条
  • [21] Post-transcriptional regulation of O6-methylguanine-DNA methyltransferase MGMT in glioblastomas
    Ramakrishnan, Valya
    Kushwaha, Deepa
    Koay, Debbie C.
    Reddy, Hasini
    Mao, Ying
    Zhou, Liangfu
    Ng, Kimberly
    Zinn, Pascal
    Carter, Bob
    Chen, Clark C.
    CANCER BIOMARKERS, 2011, 10 (3-4) : 185 - 193
  • [22] Adenovirus-based strategies overcome temozolomide resistance by silencing the O6-methylguanine-DNA methyltransferase promoter
    Alonso, Marta M.
    Gomez-Manzano, Candelaria
    Bekele, B. Nebiyou
    Yung, W. K. Alfred
    Fueyo, Juan
    CANCER RESEARCH, 2007, 67 (24) : 11499 - 11504
  • [23] Expression of O6-methylguanine-DNA methyltransferase (MGMT) as a mechanism of resistance to 6-thioguanine in human malignant melanoma.
    Gopas, J
    Gefen, N
    Galron, D
    Priel, E
    Brkic, G
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9126S - 9126S
  • [24] Acquired resistance to 6-thioguanine in melanoma cells involves the repair enzyme O6-methylguanine-DNA methyltransferase (MGMT)
    Gefen, Nir
    Brkic, Gordana
    Galron, Dalia
    Priel, Esther
    Ozer, Janet
    Benharroch, Daniel
    Gopas, Jacob
    CANCER BIOLOGY & THERAPY, 2010, 9 (01) : 49 - 55
  • [25] Variation of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma
    Parkinson, Jonathon F.
    Wheeler, Helen R.
    Clarkson, Adele
    McKenzie, Catriona A.
    Biggs, Michael T.
    Little, Nicholas S.
    Cook, Raymond J.
    Messina, Marinella
    Robinson, Bruce G.
    McDonald, Kerrie L.
    JOURNAL OF NEURO-ONCOLOGY, 2008, 87 (01) : 71 - 78
  • [26] Evaluation of O6-methylguanine-DNA methyltransferase by immunohistochemistry: Best clinical and research practices
    Cirullo Neto, Julio
    Carvalho, Katia
    Olivieri, Eloisa
    Carraro, Dirce
    Cunha, Isabela
    Vassallo, Jose
    Kagohara, Luciane
    Soares, Fernando
    Rocha, Rafael
    PATHOLOGY RESEARCH AND PRACTICE, 2011, 207 (08) : 492 - 497
  • [27] Variation of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma
    Jonathon F. Parkinson
    Helen R. Wheeler
    Adele Clarkson
    Catriona A. McKenzie
    Michael T. Biggs
    Nicholas S. Little
    Raymond J. Cook
    Marinella Messina
    Bruce G. Robinson
    Kerrie L. McDonald
    Journal of Neuro-Oncology, 2008, 87 : 71 - 78
  • [28] Effects of O6-methylguanine-DNA methyltransferase (MGMT) polymorphisms on cancer: a meta-analysis
    Zhong, Yu
    Huang, Yongsheng
    Huang, Yan
    Zhang, Tianbao
    Ma, Chengying
    Zhang, Shuyong
    Fan, Weiwei
    Chen, Hongyan
    Qian, Ji
    Lu, Daru
    MUTAGENESIS, 2010, 25 (01) : 83 - 95
  • [29] Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status
    Delia Kurzwelly
    Martin Glas
    Patrick Roth
    Elke Weimann
    Hanns Lohner
    Andreas Waha
    Martin Schabet
    Guido Reifenberger
    Michael Weller
    Ulrich Herrlinger
    Journal of Neuro-Oncology, 2010, 97 : 389 - 392
  • [30] Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status
    Kurzwelly, Delia
    Glas, Martin
    Roth, Patrick
    Weimann, Elke
    Lohner, Hanns
    Waha, Andreas
    Schabet, Martin
    Reifenberger, Guido
    Weller, Michael
    Herrlinger, Ulrich
    JOURNAL OF NEURO-ONCOLOGY, 2010, 97 (03) : 389 - 392
12345